Clinical trial
Anticoagulation Therapies Effect on the Endometrial Blood Flow and Pregnancy Outcomes in Unexplained Recurrent Implantation Failure Women
NCT03365466 is registered in ClinicalTrials.gov with Shanghai First Maternity and Infant Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anticoagulation Therapies Effect on the Endometrial Blood Flow and Pregnancy Outcomes in Unexplained Recurrent Implantation Failure Women
- Lead sponsor
- Shanghai First Maternity and Infant Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 31, 2017
- Completion date
- February 28, 2019
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent implantation failure